FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313579062> ?p ?o ?g. }

• W4313579062 endingPage "135" @default.
• W4313579062 startingPage "125" @default.
• W4313579062 abstract "Background: Targeted therapy of Neurofibromatosis type 1 (NF1) related plexiform neurofibroma (pNF) aiming at MEK molecule has not demonstrated a convincing result for complete disease inhibition, probably due to other signal pathways crosstalk. Our previous study revealed an increased nuclear translocation of YAP molecule in NF1 related pNF. Herein, we decided to further investigate the therapeutic relations of YAP interference during the MEK treatment against NF1 related pNF. Methods: By means of selumetinib (MEK-inhibitor), RNA-sequencing was firstly performed to identify the changes of signal pathways in pNF Schwann cells, which was probably related to YAP regulation. Nuclear-cytoplasmic fractionation and western blotting were performed to show the intracellular YAP changes under selumetinib treatment. Thirdly, a series of in vitro assays were performed including flow cytometry, CCK-8, and colony/sphere formation under dual treatment of selumetinib and verteporfin (YAP-inhibitor). In addition, Chou-Talalay method was adopted to evaluate the synergistic inhibiting effects of such drug combination. Xenograft study was also used to detect the combining effects in vivo. Results: RNA-sequencing revealed that selumetinib treatment might be associated with the undesirable activation of Hippo pathway in NF1 related pNF tumor cells, which might reduce its pharmaceutic effects. Next, nuclear-cytoplasmic fractionation and further studies demonstrated that selumetinib could promote the nuclear translocation and transcriptional activation of YAP in vitro, which might cause the aforementioned resistance to selumetinib treatment. Additionally, when combined treatments were performed based on verteporfin and selumetinib, synergistic effects were observed on cytotoxicity of NF1 related pNF tumor cells in vitro and in vivo xenograft models. Conclusion: YAP inhibition can effectively sensitize NF1 related pNF tumor cells to selumetinib. Dual targeting of YAP and MEK might be a promising therapeutic strategy for treating NF1 related pNF." @default.
• W4313579062 created "2023-01-06" @default.
• W4313579062 creator A5013240145 @default.
• W4313579062 creator A5025290467 @default.
• W4313579062 creator A5042533031 @default.
• W4313579062 creator A5064505837 @default.
• W4313579062 creator A5075804356 @default.
• W4313579062 creator A5076671311 @default.
• W4313579062 creator A5081301252 @default.
• W4313579062 creator A5089054644 @default.
• W4313579062 date "2023-01-01" @default.
• W4313579062 modified "2023-10-02" @default.
• W4313579062 title "Inhibition of YAP Sensitizes the Selumetinib Treatment for Neurofibromatosis Type 1 Related Plexiform Neurofibroma" @default.
• W4313579062 cites W1969104713 @default.
• W4313579062 cites W2037945967 @default.
• W4313579062 cites W2056866789 @default.
• W4313579062 cites W2079015343 @default.
• W4313579062 cites W2096439168 @default.
• W4313579062 cites W2098584395 @default.
• W4313579062 cites W2100641053 @default.
• W4313579062 cites W2122666474 @default.
• W4313579062 cites W2130848213 @default.
• W4313579062 cites W2137224782 @default.
• W4313579062 cites W2141484415 @default.
• W4313579062 cites W2148056172 @default.
• W4313579062 cites W2533523025 @default.
• W4313579062 cites W2567378356 @default.
• W4313579062 cites W2591172233 @default.
• W4313579062 cites W2600392992 @default.
• W4313579062 cites W2731528188 @default.
• W4313579062 cites W2785658517 @default.
• W4313579062 cites W2896857268 @default.
• W4313579062 cites W2940595490 @default.
• W4313579062 cites W2986966718 @default.
• W4313579062 cites W3000285141 @default.
• W4313579062 cites W3010907970 @default.
• W4313579062 cites W3025216172 @default.
• W4313579062 cites W3027443262 @default.
• W4313579062 cites W3036513507 @default.
• W4313579062 cites W3040570144 @default.
• W4313579062 cites W3084438848 @default.
• W4313579062 cites W3106046349 @default.
• W4313579062 cites W3123814388 @default.
• W4313579062 cites W3134061895 @default.
• W4313579062 cites W3139050665 @default.
• W4313579062 cites W3189798611 @default.
• W4313579062 cites W4206916073 @default.
• W4313579062 doi "https://doi.org/10.7150/ijms.78386" @default.
• W4313579062 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36619222" @default.
• W4313579062 hasPublicationYear "2023" @default.
• W4313579062 type Work @default.
• W4313579062 citedByCount "2" @default.
• W4313579062 countsByYear W43135790622023 @default.
• W4313579062 crossrefType "journal-article" @default.
• W4313579062 hasAuthorship W4313579062A5013240145 @default.
• W4313579062 hasAuthorship W4313579062A5025290467 @default.
• W4313579062 hasAuthorship W4313579062A5042533031 @default.
• W4313579062 hasAuthorship W4313579062A5064505837 @default.
• W4313579062 hasAuthorship W4313579062A5075804356 @default.
• W4313579062 hasAuthorship W4313579062A5076671311 @default.
• W4313579062 hasAuthorship W4313579062A5081301252 @default.
• W4313579062 hasAuthorship W4313579062A5089054644 @default.
• W4313579062 hasBestOaLocation W43135790621 @default.
• W4313579062 hasConcept C185592680 @default.
• W4313579062 hasConcept C2776087337 @default.
• W4313579062 hasConcept C2778984943 @default.
• W4313579062 hasConcept C2781249067 @default.
• W4313579062 hasConcept C502942594 @default.
• W4313579062 hasConcept C54355233 @default.
• W4313579062 hasConcept C57074206 @default.
• W4313579062 hasConcept C62478195 @default.
• W4313579062 hasConcept C86803240 @default.
• W4313579062 hasConcept C95444343 @default.
• W4313579062 hasConcept C98274493 @default.
• W4313579062 hasConceptScore W4313579062C185592680 @default.
• W4313579062 hasConceptScore W4313579062C2776087337 @default.
• W4313579062 hasConceptScore W4313579062C2778984943 @default.
• W4313579062 hasConceptScore W4313579062C2781249067 @default.
• W4313579062 hasConceptScore W4313579062C502942594 @default.
• W4313579062 hasConceptScore W4313579062C54355233 @default.
• W4313579062 hasConceptScore W4313579062C57074206 @default.
• W4313579062 hasConceptScore W4313579062C62478195 @default.
• W4313579062 hasConceptScore W4313579062C86803240 @default.
• W4313579062 hasConceptScore W4313579062C95444343 @default.
• W4313579062 hasConceptScore W4313579062C98274493 @default.
• W4313579062 hasIssue "1" @default.
• W4313579062 hasLocation W43135790621 @default.
• W4313579062 hasLocation W43135790622 @default.
• W4313579062 hasLocation W43135790623 @default.
• W4313579062 hasOpenAccess W4313579062 @default.
• W4313579062 hasPrimaryLocation W43135790621 @default.
• W4313579062 hasRelatedWork W2053013114 @default.
• W4313579062 hasRelatedWork W2080686146 @default.
• W4313579062 hasRelatedWork W2085971843 @default.
• W4313579062 hasRelatedWork W2103749352 @default.
• W4313579062 hasRelatedWork W2381340599 @default.
• W4313579062 hasRelatedWork W2505698301 @default.
• W4313579062 hasRelatedWork W2887208324 @default.

• next